Market Cap
$5.4B
RDNT
RadNet, Inc.
$69.93 ▲ +3.29%
Prev close $67.70Market cap$5.4B
ConsensusStrong Buy
12-mo target$94.63 (+35.3%)
▲ Bullish
Analyst conviction 9/10
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)24 New Institutional Positions26 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on RDNT right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (93%)
Inst. Holders
50 funds
Inst. Value
$3.5B
Inst. Activity
24 buys / 26 sells
Insider Activity
$0.00 buy / $4.8M sell
Insider Net $
-$4.8M
Social Sentiment
50° Neutral
SEC Reports
8
Press Releases
6
Price chart 30d -6.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 contract
Aug 10, 2026 SEC RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
RadNet and WIN-NextGen collaborate on a new program that introduces students and young adults to car
RadNet reported record Q2 2026 revenue of $622.7M (+25.0% YoY) and record Adjusted EBITDA of $99.7M (+22.7% YoY), driven
8-K — Impact 6/10
RadNet reported Q2 2026 revenue of $622.7M (+25% YoY), beating consensus of $609.3M, but GAAP EPS of $0.10 missed the $0
PRESS-RELEASE — Impact 6/10
Jun 30, 2026 Inst.
AMERICAN CENTURY COMPANIES INC — ADD
1,618,424 shares ($99.8M)
Jun 30, 2026 Inst.
Jun 25, 2026 Press BAMCO INC /NY/ — ADD
1,260,992 shares ($77.8M)
DeepHealth, a wholly owned subsidiary of RadNet (RDNT), received FDA 510(k) clearances for two new breast imaging AI fun
Impact 5/10
Jun 18, 2026 Insider
SWARTZ DAVID L sold 2,699 shares
Director @ $53.89 ($145.4K)
Jun 16, 2026 Insider
Wesdorp Cornelis sold 4,750 shares
Pres & CEO, Digital Health @ $58.11 ($276.0K)
Analyst ratings buy % +1.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
93% rate it Buy or better · 14 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 28, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Aug 11, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| May 20, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Apr 21, 2026 | Barclays | MAINTAIN | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Aug 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Jul 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Jun 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| May 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Apr 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Mar 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Feb 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% |
Price targets
Where 8 covering analysts think RDNT trades over the next 12 months.
$94.63 +35.3% upside Strong Buy
Current$69.93 Low$79.00 Median$95.50 High$105.00 8 analysts
$79.00$105.00
Analyst rating Strong Buy· 1.3/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
8 SEC filing reports analyzed · 2 bullish, 0 bearish, 3 mixed, 3 neutral · avg impact 5.5/10.Plus 6 press releases.
MIXED8-K6/10
RadNet reported record Q2 2026 revenue of $622.7M (+25.0% YoY) and record Adjusted EBITDA of $99.7M
Aug 10, 2026
MIXEDPRESS-RELEASE6/10
RadNet reported Q2 2026 revenue of $622.7M (+25% YoY), beating consensus of $609.3M, but GAAP EPS of
Aug 9, 2026
NEUTRAL8-K5/10
RadNet upsized its term loan by $250M to $250.0M through Incremental Amendment No. 3 to its Credit &
Jun 10, 2026
NEUTRAL8-K4/10
RadNet announced a proposed $200 million incremental term loan under its existing first lien credit
Jun 3, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
contract
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
RadNet and WIN-NextGen collaborate on a new program that introduces students and young adults to careers in radiology.
Sep 15, 2026
short_volume
Short Volume: RDNT — 68.2% short (0.4M / 0.6M)
Short: 403,283 | Exempt: 0 | TRF Vol: 591,452 | Short Ratio: 68.2% | Off-exchange volume (dark pool + OTC)
Sep 9, 2026
earnings
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic im
Sep 9, 2026
other
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
RadNet hosts a free prostate cancer webinar featuring physician insights, a survivor’s story and a live Q&A on screening and treatment.
Sep 9, 2026
ftd
FTD: RDNT — 10,166 shares ($0.7M) failed to deliver
Settlement: 20260909, Price: $71.97, FTD Value: $731,647.02, RadNet, Inc. Common Stock
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.22 | $0.16–$0.29 | 10.7% | +0.0% | 1↑ 4↓ | $0.6B | 7 |
| Next Q | $0.27 | $0.19–$0.34 | 18.0% | +0.0% | 0↑ 5↓ | $0.7B | 7 |
| Current FY | $0.51 | $0.38–$0.64 | 31.9% | +0.0% | 4↑ 3↓ | $2.5B | 7 |
| Next FY | $0.89 | $0.32–$1.22 | 72.4% | +0.0% | 1↑ 3↓ | $2.8B | 6 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.221 | — |
| 7d ago | $0.221 | — |
| 30d ago | $0.221 | — |
| 60d ago | $0.255 | -0.034 |
| 90d ago | $0.255 | -0.034 |
Institutional ownership
Which big funds own RDNT (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $3.5B total value (57,494,568 shares) as of 2026-Q2. Top holders: NOMURA, BlackRock,, RTW. Net selling activity: 26 institutions trimmed/exited vs 24 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0.00 | 0.0% | — |
| BlackRock, Inc. | 10,957,808 | $675.8M | 19.0% | — |
| RTW INVESTMENTS, LP | 4,846,958 | $298.9M | 8.4% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,066,931 | $250.8M | 7.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,193,565 | $196.9M | 5.6% | — |
| STATE STREET CORP | 2,842,457 | $175.2M | 4.9% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 1,858,508 | $114.6M | 3.2% | — |
| Invesco Ltd. | 1,641,292 | $101.2M | 2.9% | — |
| AMERICAN CENTURY COMPANIES INC | 1,618,424 | $99.8M | 2.8% | ADD +79.4% |
| Clearbridge Investments, LLC | 1,546,652 | $95.4M | 2.7% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | ADD | 902,192 | 1,618,424 | +79.4% | $99.8M |
| BAMCO INC /NY/ | ADD | 810,066 | 1,260,992 | +55.7% | $77.8M |
| WESTFIELD CAPITAL MANAGEMENT CO LP | ADD | 531,893 | 975,542 | +83.4% | $60.2M |
| Allspring Global Investments Holdings, LLC | TRIM | 865,404 | 608,144 | -29.7% | $39.9M |
| UBS Group AG | ADD | 486,659 | 619,635 | +27.3% | $38.2M |
| VOYA INVESTMENT MANAGEMENT LLC | ADD | 417,380 | 604,907 | +44.9% | $37.3M |
| Point72 Asset Management, L.P. | TRIM | 855,372 | 492,437 | -42.4% | $30.4M |
| NORGES BANK | NEW | — | 469,820 | — | $29.0M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 46,578 | 465,622 | +899.7% | $28.7M |
| BANK OF AMERICA CORP /DE/ | TRIM | 589,610 | 420,661 | -28.7% | $25.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 35 transactions. Net -$4.8M — $0.00 bought, $4.8M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | SWARTZ DAVID L | Director | SELL | 2,699 | $53.89 | $145.4K |
| Jun 16, 2026 | Wesdorp Cornelis | Pres & CEO, Digital Health | SELL | 4,750 | $58.11 | $276.0K |
| Jun 16, 2026 | Berger Howard G | President, CEO | GIFT | 90 | — | — |
| Jun 15, 2026 | Forthuber Stephen M | Pres & CEO-Eastern Operations | SELL | 24,214 | $57.79 | $1.4M |
| Jun 15, 2026 | Forthuber Stephen M | Pres & CEO-Eastern Operations | SELL | 19,853 | $58.61 | $1.2M |
| Jun 2, 2026 | SPURLOCK GREGORY E. | Director | AWARD | 2,946 | — | — |
| Jun 2, 2026 | Levitt Lawrence L | Director | AWARD | 2,946 | — | — |
| Jun 2, 2026 | Jacobs Laura Pastre | Director | AWARD | 2,946 | — | — |
| Jun 2, 2026 | SWARTZ DAVID L | Director | AWARD | 2,946 | — | — |
| May 5, 2026 | Berger Howard G | President, CEO | EXERCISE | 25,992 | $18.64 | $484.5K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for RDNT.
Shares short
9,671,100
Settlement Sep 15, 2026
Change vs prior
-2.7%
Semi-monthly cycle
Days to cover
11.9
At avg daily volume
Of shares outstanding
≈12.3%
Estimate — not % of float
All RDNT filing & press-release reports (14)
- 8-K reportAug 10, 2026
- PRESS-RELEASE reportAug 9, 2026
- PRESS-RELEASE reportJun 25, 2026
- 8-K reportJun 10, 2026
- 8-K reportJun 3, 2026
- 8-K reportMay 11, 2026
- PRESS-RELEASE reportMay 10, 2026
- PRESS-RELEASE reportApr 28, 2026
- DEFA14A reportApr 20, 2026
- PRESS-RELEASE reportMar 11, 2026
- PRESS-RELEASE reportMar 4, 2026
- PRESS-RELEASE reportMar 2, 2026
- PRESS-RELEASE reportMar 2, 2026
- PRESS-RELEASE reportMar 2, 2026